Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-09-01 09:19 UTC

NVS remibrutinib shows favorable Phase III RMS results

TradeXchange Newsdesk says NVS remibrutinib reduced relapse rates and had a favorable safety profile in Phase III RMS trials.